# Editorial: Hospital management and healthcare policy: financing, resourcing and accessibility, volume II

**Authors:** Thomas T. H. Wan, Jay Shen, Hanadi Y. Hamadi

PMC · DOI: 10.3389/fpubh.2025.1699910 · Frontiers in Public Health · 2025-10-16

## Full-text entities

- **Diseases:** cancer (MESH:D009369), diabetes (MESH:D003920), ES-SCLC (MESH:D055752), mTNBC (MESH:D064726), Type 2 diabetes (MESH:D003924), SSI (MESH:D013530), infection (MESH:D007239)
- **Chemicals:** tislelizumab (MESH:C000707970), toripalimab (MESH:C000656314), platinum (MESH:D010984), glucose (MESH:D005947), etoposide (MESH:D005047)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12571861/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12571861/full.md

## References

16 references — full list in the complete paper: https://tomesphere.com/paper/PMC12571861/full.md

---
Source: https://tomesphere.com/paper/PMC12571861